GFPT2 and cardiac hypertrophy: We previously found that the pharmacological inhibition of GFAT suppressed increases in O‐GlcNAcylation and phosphorylation of Akt in the heart of isoproterenol‐induced cardiac hypertrophy mice, thereby suppressing cardiac hypertrophy to approximately normal level [15].